Search Results for: medical

Paper with duplicated image “sequentially builds” on neuroscience work, authors argue

A neurochemistry journal has retracted a paper from a group in China over a duplicated image. According to the notice, the authors used the same image in the two papers to represent different experimental conditions. The only distinguishing feature between the images: “apparent brightness changes.” The authors defended their actions, explaining that the research published in Journal of … Continue reading Paper with duplicated image “sequentially builds” on neuroscience work, authors argue

Authors retract much-debated blockchain paper from F1000

The authors of a popular — and heavily debated — F1000Research paper proposing a method to prevent scientific misconduct have decided to retract it. The paper was initially criticized for allegedly plagiarizing from a graduate student’s blog — and revised to try to “rectify the overlap.” But according to F1000, it is now being retracted after an additional … Continue reading Authors retract much-debated blockchain paper from F1000

Could bogus scientific results be considered false advertising?

Could a scientific paper ever be considered an advertisement? That was the question posed to a Tokyo court, in a criminal case where prosecutors argued — at the behest of Japan’s ministry of health — that a peer-reviewed paper containing faked data should be considered “fraudulent or exaggerated advertising” under that country’s laws. In that case, … Continue reading Could bogus scientific results be considered false advertising?

Weekend reads: Prison for sharing an article?; which country has most fake peer review retractions; counterfeit reagents

The week at Retraction Watch featured a look at a school where everyone has published in possibly predatory journals, and doubts about a study of doing math unconsciously. Here’s what was happening elsewhere:

Updated: Vaccine-autism study retracted — again

For the second time, a journal has quickly retracted a study that suggested vaccines raise the risk of autism and other neurodevelopmental disorders. The study first raised a furor last year, prompting a Frontiers journal to quickly retract it. After it was republished in the Journal of Translational Science this month, that journal has also retracted it. … Continue reading Updated: Vaccine-autism study retracted — again

PLOS upgrades flag on controversial PACE chronic fatigue syndrome trial; authors “surprised”

PLOS ONE has issued an expression of concern after the authors of a controversial study about chronic fatigue syndrome declined to share some of their data. In an unusual move, the journal included the authors’ response to the expression of concern (EOC), in which they strongly argue against the notice, and “do not accept that it … Continue reading PLOS upgrades flag on controversial PACE chronic fatigue syndrome trial; authors “surprised”

Peer review in 2030: New report hopes it’s faster, more transparent, and more diverse

Over the decades, the concept of peer review has changed dramatically – so what does the future hold? That’s a question examined in a new report issued today by BioMed Central and Digital Science, based on discussions held during the SpotOn London conference. (Disclosure: Our co-founder Ivan Oransky spoke there.) We spoke with Elizabeth Moylan, Senior … Continue reading Peer review in 2030: New report hopes it’s faster, more transparent, and more diverse

Weekend reads: New calls for retraction; more on fake peer review; how long does peer review take?

The week at Retraction Watch featured a look at how long journals take to respond to retraction requests, and news of a $10 million settlement for research misconduct allegations. Here’s what was happening elsewhere: